Hijacking a morphogenesis proteinase for cancer cell invasion by Akhtar, N.
This is a repository copy of Hijacking a morphogenesis proteinase for cancer cell invasion.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/138148/
Version: Accepted Version
Article:
Akhtar, N. orcid.org/0000-0002-5099-8767 (2018) Hijacking a morphogenesis proteinase 
for cancer cell invasion. Developmental Cell, 47 (2). pp. 135-137. ISSN 1534-5807 
https://doi.org/10.1016/j.devcel.2018.10.007
Article available under the terms of the CC-BY-NC-ND licence 
(https://creativecommons.org/licenses/by-nc-nd/4.0/).
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 
(CC BY-NC-ND) licence. This licence only allows you to download this work and share it with others as long 
as you credit the authors, but you can’t change the article in any way or use it commercially. More 
information and the full terms of the licence here: https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
 Hijacking a morphogenesis proteinase for cancer cell invasion 
 
Nasreen Akhtar1*  
1Department of Oncology and Metabolism, The Bateson Centre, University of Sheffield, 
Beech Hill Road, Sheffield. 
*Correspondence: n.akhtar@sheffield.ac.uk 
 
 
Abstract:  
A long-standing question in biology is whether cancer cells exploit developmental processes 
to invade the surrounding stroma. In this issue of Developmental Cell, Feinberg et al. (2018), 
identify the matrix metalloproteinase Mmp14 as a key driver of mammary invasion common 
to both development and cancer, but expose an underlying twist.  
 
The mammary gland is one of the few organs in the body that undergoes most of its 
development post-natally.  Its growth is primarily activated in adolescent females where 
epithelial tubes rapidly sprout into a ductal tree.  Epithelia within the mammary gland are 
also precursors of breast cancer, a disease that only develops in adulthood.  Mammary 
ducts are compartmentalised into a bi-layer of inner luminal epithelia and outer myoepithelia. 
At their ends is a specialized structure called the terminal end bud, containing a reservoir of 
cell types required for duct elongation.  Each tube is covered by a laminin-rich basement 
membrane (BM) embedded in a fibrous collagen matrix with stromal cells and surrounded by 
adipose tissue (Figure 1a).  Post-natal duct extension in the developing mammary gland 
requires invasion through the stromal matrix and fat pad; likewise breast cancer cells invade 
the BM and stroma to spread to other parts of the body (Cheung et al., 2013).  A long-
standing question is whether they use the same components and mechanisms.  Part of the 
problem is that we do not fully understand the processes involved in the tightly controlled 
developmental invasion.  In this issue of Developmental Cell, Feinberg and colleagues 
(Feinberg et al., 2018) take advantage of the unique post-natal growth and remodelling 
properties of the mammary gland to identify a common component of tissue invasive 
programs utilized in branching morphogenesis and in neoplastic invasion, revealing an 
unexpected twist.   
 
Controlled degradation and remodelling of the extracellular matrix (ECM) by matrix 
metalloproteinases (MMPs) is essential for branching morphogenesis (Khokha and Werb, 
2011).  Feinberg et al. (2018) focussed on two membrane-bound MMPs, Mmp14 and 
Mmp15, that degrade both BM and stromal ECM components (Feinberg et al., 2016). Using 
elegant in vivo approaches, they first showed that both of these proteinases are present in 
the growing duct epithelium. Unexpectedly however, removal of either Mmp14 or Mmp15 in 
epithelial cells did not perturb duct outgrowth.  This came as a surprise as Mmp14 has 
previously been shown to regulate branching morphogenesis in vitro (Feinberg et al., 2016; 
Mori et al., 2013).  Branching morphogenesis also proceeded normally in mice lacking both 
epithelial specific Mmp14 and -15 excluding the possibility of redundant roles.  Leaving no 
stone unturned, the authors then transplanted tiny bits of ducts lacking epithelial Mmp14 into 
cleared mammary fat pads of compatible females; these also branched out normally.  By 
contrast, in a mouse mammary epithelial carcinoma model, epithelial targeting of Mmp14 but 
not Mmp15 blocked invasion and metastasis both in vivo and in organoid culture.  The 
findings were reproduced in patient-derived xenografts, where blocking Mmp14 prevented 
human organoid invasion in collagen gels.  Hence epithelial targeting of Mmp14 blocks 
invasion in cancer cells but not postnatal duct extension.  
 
To understand this perplexing result, the authors decided to tamper with the proteinases in 
the periductal stromal compartment.  Targeting stromal cell Mmp14 severely blocked post-
natal duct extension without altering duct architecture. In contrast, targeting Mmp14 in the 
stromal compartment of mammary carcinomas failed to block tumour cell invasion in vivo.  
Thus Mmp14 is a common factor that drives invasion in both developmental duct penetration 
and cancer cell invasion but the cellular compartments that control the Mmp14-mediated 
invasion are distinct.  Post-natal duct growth and penetration through the ECM is tightly 
policed by the stromal fibroblasts, while cancer cells escape this regulation and appear to do 
the job of hacking through the ECM all by themselves (Figure 1b.c). 
Why cancer cells exploit their cell-surface Mmp14 while healthy duct epithelia do not is not 
entirely clear.  The ECM environment might contribute, given that duct epithelia are 
separated from the stromal matrix by a BM (rich in collagen IV) whereas cancer cells breach 
this barrier and directly touch the stromal ECM (rich in collagen I). Indeed cell-surface 
stabilisation of Mmp14 is regulated by collagen I ECM (Lafleur et al., 2006).  Moreover, duct 
organoids, when embedded in collagen I hydrogels, manifest a dependency on Mmp14 for 
branching out but do not require this proteinase when embedded within a reconstituted BM 
(Feinberg et al., 2016).  In vivo, thinning of the BM is commonly seen around the tips of 
rapidly growing ducts and tiny gaps in the BM do form, but whether the duct epithelia ever 
directly touch the stroma remains unclear. Regardless, contact with the stroma may not 
explain everything. In neoplasia, for example, Mmp14 may also be activated independently 
of stromal collagen I, as this proteinase has previously been shown to bestow cancer cells 
with the ability to degrade the BM (Ota et al., 2009).  Furthermore, in the present study, 
tumours lacking Mmp14 have a thickened BM suggesting that at least some of the invasive 
activity might be halted at the cell-BM axis. Finally, Mmp14 also activates pro-Mmp2, which 
degrades BM components and is linked to breast cancer progression (Strongin et al., 1995). 
 
Given that Mmp14 has both proteolytic and non-proteolytic roles. (Mori et al., 2013), the 
authors examined further the potential role of proteolysis by searching for evidence of 
stromal collagen remodelling.  Using a collagen-hybridising peptide, the authors revealed 
collagen degradation proximal to the growing regions of mammary ducts.  They also found 
increased periductal collagen in the stroma of Mmp14 null glands, suggesting loss of 
proteolytic ECM degradation.  Moreover, branching morphogenesis failed to proceed in 
mutant mice expressing a non-degradable collagen I, similar to the stromal-depleted Mmp14.  
In both models, however, there was a severe block in proliferation of the epithelial and 
stromal cells, which probably accounts for the bulk loss of duct extension in vivo.  
Interestingly, Mmp2 and Mmp11 knockout mice also exhibit a similar defect in duct 
outgrowth (Wiseman et al., 2003).  
 
These findings  support a proteolytic role for Mmp14, but how ECM degradation is linked to 
post-natal duct extension remains unclear.  In particular, if forward progression of ducts is 
blocked as a result of improper ECM remodelling, why do the epithelial tubes not continue to 
grow perpendicular to their long axis or into the lumen? It is thus possible that the proteolytic 
role of MMPs goes beyond just Ôclearing the pathÕ for invading ducts.  It may also enable cell 
signalling, for example by releasing growth factors tethered to the ECM or exposing cryptic 
integrin binding sites (Sternlicht and Werb, 2001).  Hence a block in this signalling axis could 
easily perturb tissue proliferation.   
 
Another important finding in the present study is that a thickened periductal stromal matrix is 
not sufficient to support carcinoma cell invasion. Without Mmp14 the stromal matrix 
increased in density, but neither the tumours nor healthy breast cells were able to invade.  
Moreover, tumour organoids embedded in a non-degradable collagen I matrix in vitro 
displayed reduced invasion. Thus, a more dense stromal matrix is not sufficient to promote 
invasion without Mmp14 to help navigate through the ECM.  
 
In conclusion, neoplasia can reactivate developmental molecules in invasive programs but 
not necessarily in an identical manner. At least for Mmp14, the job switches from one breast 
compartment to another. 
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Figure legends: 
Figure 1:  Extracellular matrix remodelling by Mmp14 in mammary gland development 
and cancer. 
a) Schematic of a mammary duct with a terminal end bud, depicting the epithelial and 
stromal compartments. 
b) In branching morphogenesis penetration through the ECM is tightly controlled by stromal 
fibroblast-derived Mmp14. 
c) Epithelial cancer cells utilize their own Mmp14 to invade through the ECM. 
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